Will SURTAVI change my practice: TAVI for patients with intermediate risk?

Chairpersons: N. Moat, D. Tchétché
Session reporter: D. Jones

Summary

Will SURTAVI change my practice: TAVI for patients with intermediate risk? In this session, review the trial results for SURTAVI, learn how patient selection defines outcomes in TAVI and AVR and relate the findings of this trials to your patient population and practice.

Learning Objectives

  • To review trial results for SURTAVI
  • To learn how patient selection defines outcomes in TAVI and AVR
  • To relate the findings of this trial to your patient population and practice in Europe and the US

Presentations available when logged in:

  • Introduction - the trial headlines
  • A representative case with intermediate risk
  • What was known before SURTAVI
  • Trial(ist) review: methods, results, conclusions
  • Case conclusion SURTAVI: how does this apply to my practice?
  • Concluding remarks